< Back to situations

[ORGANIZATION]

Agência Brasil

Featured in 9 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [BR] [GB] [US]

Brazil's aging population: Demographic and social shifts

23 clusters · 96 sources · last updated

Latest: Brazil's aging population drives fitness and silver economy growth

Brazil’s demographic shift continues to reshape social, economic, and political structures. With the elderly population projected to reach nearly 40% by 2070, the country is on track to become the fifth largest populatio

[QUIET] [BUSINESS] [BR]

Brazil Tesouro Direto investment trends

2 clusters · 21 sources · last updated

Latest: Tesouro Direto investments reach record R$ 15 billion in August

Brazil’s Tesouro Direto program reached a historic milestone in August 2026, recording R$ 15 billion in investments through 1.32 million operations. This represents the highest monthly volume since the program’s inceptio

[QUIET] [POLITICS] [BR]

Brazilian states set varying alcohol restrictions for 2026

3 clusters · 35 sources · last updated

Latest: Brazil elections 2026: Alcohol restrictions vary by state

As Brazil approaches the 2026 elections, several states are implementing varying public security measures regarding the sale of alcohol, known as ‘Lei Seca’. Because there is no single federal mandate from the Superior E

[QUIET] [HEALTH] [BR]

Alopecia areata medical overview

2 clusters · 20 sources · last updated

Latest: Alopecia areata causes unpredictable hair loss in 2% of population

Alopecia areata is an unpredictable autoimmune condition affecting approximately 2% of the global population. According to dermatologist Enilde Borges Costa of the Brazilian Society of Dermatology (SBD), the disease occu

[QUIET] [HEALTH] [BR] [MX] [TR]

Body image and GLP-1 medication trends in Brazil

6 clusters · 91 sources · last updated

Latest: Health experts warn against risks of rapid weight loss

Health experts and regulatory bodies in Brazil continue to intensify warnings regarding the use of GLP-1 receptor agonists, such as semaglutide and tirzepatide, for weight loss. While effective for obesity, a systematic

Also covered in